Suppr超能文献

电子健康记录中肾移植数据的可推广性——Epic Cosmos数据库与移植受者科学登记处的比较

Generalizability of kidney transplant data in electronic health records - The Epic Cosmos database vs the Scientific Registry of Transplant Recipients.

作者信息

Mankowski Michal A, Bae Sunjae, Strauss Alexandra T, Lonze Bonnie E, Orandi Babak J, Stewart Darren, Massie Allan B, McAdams-DeMarco Mara A, Oermann Eric K, Habal Marlena, Iturrate Eduardo, Gentry Sommer E, Segev Dorry L, Axelrod David

机构信息

Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA.

Department of Surgery, NYU Grossman School of Medicine, New York, New York, USA; Department of Population Health, NYU Grossman School of Medicine, New York, New York, USA.

出版信息

Am J Transplant. 2025 Apr;25(4):744-755. doi: 10.1016/j.ajt.2024.11.008. Epub 2024 Nov 15.

Abstract

Developing real-world evidence from electronic health records (EHR) is vital to advancing kidney transplantation (KT). We assessed the feasibility of studying KT using the Epic Cosmos aggregated EHR data set, which includes 274 million unique individuals cared for in 238 US health systems, by comparing it with the Scientific Registry of Transplant Recipients (SRTR). We identified 69 418 KT recipients who underwent transplants between January 2014 and December 2022 in Cosmos (39.4% of all US KT transplants during this period). The demographics and clinical characteristics of recipients captured in Cosmos were consistent with the overall SRTR cohort. Survival estimates were generally comparable, although there were some differences in long-term survival. At 7 years posttransplant, patient survival was 80.4% in Cosmos and 77.8% in SRTR. Multivariable Cox regression showed consistent associations between clinical factors and mortality in both cohorts, with minor discrepancies in the associations between death and both age and race. In summary, Cosmos provides a reliable platform for KT research, allowing EHR-level clinical granularity not available with either the transplant registry or health care claims. Consequently, Cosmos will enable novel analyses to improve our understanding of KT management on a national scale.

摘要

从电子健康记录(EHR)中生成真实世界证据对于推进肾移植(KT)至关重要。我们通过将Epic Cosmos汇总的EHR数据集与移植受者科学注册系统(SRTR)进行比较,评估了使用该数据集研究KT的可行性。Epic Cosmos数据集包含在美国238个医疗系统中接受治疗的2.74亿独特个体。我们确定了2014年1月至2022年12月期间在Cosmos中接受移植的69418名KT受者(占该时期美国所有KT移植的39.4%)。Cosmos中记录的受者人口统计学和临床特征与整个SRTR队列一致。生存估计总体上具有可比性,尽管长期生存存在一些差异。移植后7年,Cosmos中的患者生存率为80.4%,SRTR中的为77.8%。多变量Cox回归显示,两个队列中临床因素与死亡率之间的关联一致,死亡与年龄和种族之间的关联存在细微差异。总之,Cosmos为KT研究提供了一个可靠的平台,允许进行移植登记或医疗保健索赔无法提供的EHR级临床粒度分析。因此,Cosmos将能够进行新颖的分析,以提高我们在全国范围内对KT管理的理解。

相似文献

引用本文的文献

1
Finding actionable information in the universe of data.在海量数据中寻找可付诸行动的信息。
Am J Transplant. 2025 Apr;25(4):648-649. doi: 10.1016/j.ajt.2025.01.004. Epub 2025 Jan 16.

本文引用的文献

8
Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.美国 JYNNEOS 疫苗对猴痘疾病的有效性。
N Engl J Med. 2023 Jun 29;388(26):2434-2443. doi: 10.1056/NEJMoa2215201. Epub 2023 May 18.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验